Acaa1b Inhibitors

Chemical inhibitors of Acaa1b function primarily by interfering with the metabolic pathways that provide the substrates necessary for its enzymatic activity. Etomoxir, for instance, targets carnitine palmitoyltransferase-1 (CPT1), a key enzyme in the transport of long-chain fatty acids into the mitochondria. By inhibiting CPT1, Etomoxir reduces the influx of fatty acids into the mitochondria, which subsequently lowers the availability of substrate for Acaa1b, whose role is to catalyze the final step of β-oxidation. Similarly, Perhexiline disrupts fatty acid metabolism by inhibiting mitochondrial carnitine acylcarnitine translocase (CACT), thereby limiting the shuttling of long-chain acylcarnitines into the mitochondria and decreasing the pool of substrates required for Acaa1b's activity in β-oxidation.

Other inhibitors like Trimetazidine and Oxfenicine directly target enzymes of the β-oxidation pathway. Trimetazidine inhibits long-chain 3-ketoacyl CoA thiolase, which operates in the same enzymatic step as Acaa1b, thus directly reducing the throughput of the β-oxidation cycle. Oxfenicine inhibits carnitine acetyltransferase (CAT), which is essential for the transport of fatty acids into mitochondria, where β-oxidation takes place. This inhibition reduces the availability of fatty acids for Acaa1b to process. Additionally, compounds such as Malonyl-CoA, a natural inhibitor of CPT1, and 2-Bromopalmitate, an inhibitor of fatty acid transport and metabolism, limit the availability of fatty acid substrates for Acaa1b, curtailing the enzyme's activity. CPI-613, although not directly involved in fatty acid β-oxidation, can influence the metabolic environment in which Acaa1b operates by targeting mitochondrial complexes crucial for energy metabolism, which may indirectly affect the enzyme's function. ST1326's selective inhibition of carnitine octanoyltransferase (COT) also has a similar effect on Acaa1b activity by reducing the transport of fatty acids into the mitochondria for β-oxidation. Through these varied mechanisms, these inhibitors contribute to the regulation of Acaa1b's activity by modulating the availability of its substrates within the mitochondria.